
doi: 10.1002/bjs.6436
pmid: 19109800
Abstract Background Bilobar colorectal metastases are a therapeutic challenge and require a multidisciplinary approach. The aim of this study was to describe the clinical and histological outcomes of patients having neoadjuvant chemotherapy and two-step hepatectomy with right portal vein occlusion for advanced bilateral colorectal metastases. Methods A series of 23 consecutive patients treated with curative intent according to a standardized multidisciplinary management protocol was reviewed. Results Of 23 patients, 22 completed the programme. There was no mortality and no Clavien grade III morbidity. Median survival from the start of treatment was 45 months, and 1-, 3- and 5-year Kaplan–Meier estimates were 95, 73 and 27 per cent respectively. On histology at the first operation, ten patients had a dangerous halo of proliferating tumour cells infiltrating the surrounding liver parenchyma, of variable importance (six focal and four diffuse), regardless of the response to chemotherapy of the metastases. The dangerous halo increased in prevalence and importance (six focal and seven diffuse) between the first and second operation. Conclusion Neoadjuvant chemotherapy followed by two-step hepatectomy with right portal vein occlusion is feasible, safe and may be advantageous to the patient. The appearance of a dangerous halo around the liver metastases may require adaptation of the surgical technique to decrease the risk of local recurrence.
Adult, Male, Reoperation, 616.07, Hepatectomy/*methods/mortality, Chemotherapy, Adjuvant/adverse effects, 616, Antineoplastic Combined Chemotherapy Protocols, 617, Hepatectomy, Humans, *Colorectal Neoplasms, Antineoplastic Combined Chemotherapy Protocols/*adverse effects, Aged, Postoperative Care, Reoperation/mortality, Postoperative Care/mortality, Portal Vein, Liver Neoplasms, Liver Neoplasms/pathology/secondary/*therapy, Middle Aged, Embolization, Therapeutic, Survival Analysis, Treatment Outcome, Neoplasm Recurrence, Local/mortality/pathology, Chemotherapy, Adjuvant, Feasibility Studies, Female, Neoplasm Recurrence, Local, Colorectal Neoplasms, Embolization, Therapeutic/methods/mortality, ddc: ddc:616.07, ddc: ddc:616, ddc: ddc:617
Adult, Male, Reoperation, 616.07, Hepatectomy/*methods/mortality, Chemotherapy, Adjuvant/adverse effects, 616, Antineoplastic Combined Chemotherapy Protocols, 617, Hepatectomy, Humans, *Colorectal Neoplasms, Antineoplastic Combined Chemotherapy Protocols/*adverse effects, Aged, Postoperative Care, Reoperation/mortality, Postoperative Care/mortality, Portal Vein, Liver Neoplasms, Liver Neoplasms/pathology/secondary/*therapy, Middle Aged, Embolization, Therapeutic, Survival Analysis, Treatment Outcome, Neoplasm Recurrence, Local/mortality/pathology, Chemotherapy, Adjuvant, Feasibility Studies, Female, Neoplasm Recurrence, Local, Colorectal Neoplasms, Embolization, Therapeutic/methods/mortality, ddc: ddc:616.07, ddc: ddc:616, ddc: ddc:617
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 87 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
